Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 30, 2011

View Archived Issues

QLT reports promising phase II data on L-PPDS in glaucoma

Bristol-Myers Squibb small-molecule MAP kinase p38 alpha inhibitor shows promise to treat arthritis

Pfizer describes discovery and investigation of AMPA receptor modulator now in phase I

Additional analyses of AVERROES study presented

Daewoong Pharmaceutical discloses new antifungal agents

Novel plant extracts prepared by German researchers

Hanmi Holdings presents new epidermal growth factor receptor inhibitors

Nanoemulsion-based RSV vaccine achieves durable viral clearance in vivo

GSK synthesizes novel interferon inducers

N30 Pharmaceuticals patents new alcohol dehydrogenase class-3 inhibitors

U.S. universities claim novel serotonin 5-HT2C receptor agonists

Boehringer Ingelheim begins new afatinib trials in breast cancer

Stellar Biotechnologies receives National Science Foundation grant

Talon Therapeutics and FDA reach agreement on HALLMARQ trial

Novartis seeks Japanese approval of tobramycin

Pharming returns certain Ruconest marketing rights to Swedish Orphan Biovitrum

Immuron to begin clinical testing of influenza product

Ipsen and Inspiration Biopharmaceuticals sign European partnership agreement in hemophilia

FDA grants fast track status to letermovir

Brain-penetrant inhibitor of kynurenine aminotransferase II described by Pfizer

Adimab announces new collaborations

FDA clears new anti-CCP assay for diagnosis of rheumatoid arthritis

NuPathe receives FDA complete response letter regarding Zelrix NDA

FDA accepts Relistor sNDA for filing

Cyclacel announces initiation of phase II trial of sapacitabine capsules

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...